hrp0097p1-578 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2023

Klinefelter Syndrome and Fertility - Current practice in a tertiary Children’s Hospital

Alexopoulou Vasiliki , Bambang Katerina , Senniappan Senthil

Background: Klinefelter Syndrome (KS) is the most common chromosomal anomaly in males associated with infertility. Advances in assisted reproductive medicine have made conception possible for some men with KS, with increasing scientific interest gathered around semen cryopreservation and testicular biopsy for sperm extraction (TESE).Objectives: This project aims to examine the current practice in a paediatric tertiary ho...

hrp0097p1-438 | Diabetes and Insulin | ESPE2023

A qualitative study of knowledge, attitudes and perceptions of new diabetes technologies in A&E department

Alexopoulou Vasiliki , McCaffrey Liana , Mccabe Miranda , May Ng Sze

Background: In August 2022, the National Institute of Health and Care Excellence recommended that all adults and children with type 1 diabetes (T1DM) should have access to Continuous Glucose monitoring systems (CGM). This guidance will increase the number of T1DM patients who present in the A&E department and the use the new diabetes technologies in clinical practice. In addition, hybrid closed-loop (HCL) systems which integrate CGM and insulin pumps to au...

hrp0098p3-31 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

Burosumab as a treatment for x-hyposphosphametic rickets:report of two cases

Georgia Maltezou Panagiota , Bekiou Vasiliki , Alexopoulou Efthymia , Doulgeraki Artemis , Karachaliou Foteini-Eleni

Background: X-linked hypophosphatemic rickets (XLH) is a relatively rare chronic bone metabolism disorder, caused by mutations in the X chromosome's PHEX gene. Fibroblast growth factor 23 (FGF23) levels rise, and bone metabolism is affected. The monoclonal antibody burosumab represents a novel therapeutic strategy for managing XLH, targeting the pathophysiology of the disorder. We present our experience of two XLH-diagnosed pediatric patients treated with...